| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $1.8M | -72.6% |
| R&D Expense | $83K | -94.1% |
| SG&A Expense | $13.4M | -26.8% |
| Operating Income | -$23.1M | +58.0% |
| Income Tax | $0 | — |
| Net Income | -$134.9M | -166.2% |
| EPS (Basic) | -$36.73 | -2862.1% |
| EPS (Diluted) | -$36.73 | -2862.1% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $1.2M | +57.4% |
| Accounts Receivable | $239K | +12.3% |
| Inventory | $881K | -60.0% |
| Current Assets | $4.3M | -53.1% |
| Total Assets | $22.7M | -13.2% |
| Current Liabilities | $12.3M | -29.3% |
| Long-term Debt | $28.9M | -8.4% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$24.2M | -11.6% |
| Capital Expenditures | $502K | -95.7% |
| Investing Cash Flow | $180K | +102.7% |
| Financing Cash Flow | $24.5M | +117.8% |
| Free Cash Flow | -$24.7M | +25.9% |
| Total Liabilities |
| $43.1M |
| -36.6% |
| Stockholders' Equity | -$20.4M | +51.2% |